We are live on ! Find out more
NTUS

Natus Medical Inc

Delisted

NTUS was delisted on the 20th of July, 2022.

159 hedge funds and large institutions have $525M invested in Natus Medical Inc in 2020 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 46 increasing their positions, 68 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

8% less funds holding

Funds holding: 172159 (-13)

12% less call options, than puts

Call options by funds: $726K | Put options by funds: $827K

23% less capital invested

Capital invested by funds: $683M → $525M (-$158M)

32% less repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 68

35% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 34

Holders
159
Holders Change
-13
Holders Change %
-7.56%
% of All Funds
3.21%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
22
Increased
46
Reduced
68
Closed
34
Calls
$726K
Puts
$827K
Net Calls
-$101K
Net Calls Change
-$1.82M
Name Holding Trade Value Shares
Change
Change in
Stake
Los Angeles Capital Management
101
Los Angeles Capital Management
California
$303K -$95.8K -5,069 -22%
VOYA Investment Management
102
VOYA Investment Management
Georgia
$303K -$81.2K -4,296 -20%
GCP
103
GSA Capital Partners
United Kingdom
$280K +$309K +16,343 New
LSERS
104
Louisiana State Employees Retirement System
Louisiana
$269K +$122K +6,480 +70%
MIM
105
MetLife Investment Management
New Jersey
$260K
ECM
106
ExodusPoint Capital Management
New York
$248K +$274K +14,494 New
OPERF
107
Oregon Public Employees Retirement Fund
Oregon
$238K
VFA
108
Values First Advisors
Tennessee
$236K +$13K +690 +5%
SEI Investments
109
SEI Investments
Pennsylvania
$233K
AI
110
Atom Investors
Texas
$232K +$256K +13,550 New
Royal Bank of Canada
111
Royal Bank of Canada
Ontario, Canada
$229K +$1.27K +67 +0.5%
Susquehanna International Group
112
Susquehanna International Group
Pennsylvania
$224K -$214K -11,303 -46%
MSA
113
Mason Street Advisors
Wisconsin
$218K +$340 +18 +0.1%
Squarepoint
114
Squarepoint
New York
$204K -$133K -7,042 -37%
MLICM
115
Metropolitan Life Insurance Company (MetLife)
New York
$186K
II
116
Inspire Investing
Idaho
$186K +$5.94K +314 +3%
DCM
117
Dupont Capital Management
Delaware
$181K -$13.4K -709 -6%
Walleye Capital
118
Walleye Capital
New York
$180K +$198K +10,486 New
HF
119
HRT Financial
New York
$176K +$195K +10,297 New
ASRS
120
Arizona State Retirement System
Arizona
$175K +$193K +10,199 New
Bank of Montreal
121
Bank of Montreal
Ontario, Canada
$171K -$5.56K -294 -3%
BNP Paribas Financial Markets
122
BNP Paribas Financial Markets
France
$146K +$115K +6,074 +247%
IA
123
IndexIQ Advisors
New York
$139K +$8.32K +440 +6%
Public Employees Retirement Association of Colorado
124
Public Employees Retirement Association of Colorado
Colorado
$138K
TRSOTSOK
125
Teachers Retirement System of the State of Kentucky
Kentucky
$120K

NTUS Hedge Fund Activity: Q3 2020 in Review

159 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Natus Medical Inc (NTUS) for Q3 2020, worth a combined $525M — down 23% from $683M a quarter earlier.

Sellers outnumbered buyers: 34 funds closed out of NTUS and 22 opened new positions — a net loss of 12 holders — while 68 trimmed existing stakes and 46 added.

The largest buyer was Janus Henderson Group, opening a new position worth an estimated $14.4M. The largest seller was Cramer Rosenthal McGlynn, exiting entirely with an estimated $10.9M sold.

  • 159 institutional investors held Natus Medical Inc (NTUS) as of Q3 2020, down from 172 in Q2 2020.
  • Funds reported $525M of Natus Medical Inc stock for Q3 2020, down 23% quarter-over-quarter.
  • 22 funds opened new Natus Medical Inc positions in Q3 2020 and 34 closed out, a net change of -12 holders.
  • The largest Natus Medical Inc buyer in Q3 2020 was Janus Henderson Group, an estimated $14.4M added.
  • The largest Natus Medical Inc seller in Q3 2020 was Cramer Rosenthal McGlynn, an estimated $10.9M sold.

Based on aggregated 13F filings for Q3 2020.